Tokyo-1 not only develops and provides a high performance computing environment, but also forms a creative community with Xeureka and partners to collaborate in the effective and efficient utilization of AI and computational tools for drug discovery.
We aim for Tokyo-1 to become the place where companies committed to data-driven drug discovery can interact and make substantial innovations.
| Activities | Working Group (twice/month) : Knowledge sharing among partners in the fields of basic technology, DX solutions, overseas developments and cases overseas, etc. |
|---|---|
| Sub-Working Group (ad hoc): A subcommittee where representatives from each partner gather to optimize productivity and conduct verification activities. | |
| Executive Board (twice/year) : Steering committee meeting for executives from partners. | |
| Organizer | Xeureka Inc. |
| Toranomon 30 Mori Building 9F, 3-2-2 Toranomon, Minato-ku, Tokyo 105-0001, Japan |